Company gets $15 million loan and $5 million accounts receivable line
By Devika Patel
Knoxville, Tenn., Aug. 9 - NeurogesX, Inc. negotiated a $20 million financing agreement with Hercules Technology Growth Capital, Inc. on Aug. 5, according to an 8-K filed Tuesday with the Securities and Exchange Commission. The financing includes both a $5 million accounts receivable line and a $15 million term loan.
The $15 million term loan is required to be repaid over the course of 42 months, which includes a one-year interest-only period at the beginning of the term. Interest on the loan has a minimum rate of 9.5%, which can increase based on fluctuations in the Prime rate.
The $5 million accounts receivable line is a revolving line that is available until Dec. 31, 2012 and then is renewable by Hercules each year. The accounts receivable line bears interest at a minimum interest rate of 6.75%, which can also increase based on fluctuations in the Prime rate.
The company may prepay both the term loan and the accounts receivable line at any time, with a $600,000 fee when the term loan is repaid.
Hercules also received a warrant for 791,667 shares, which is exercisable at $1.80 for five years. The strike price reflects a 20.35% discount to the Aug. 4 closing share price of $2.26.
Based in San Carlos, Calif., NeurogesX is a specialty pharmaceutical company focused on neuropathic pain.
Issuer: | NeurogesX, Inc.
|
Issue: | Term loan, accounts receivable line
|
Amount: | $20 million
|
Warrants: | For 791,667 shares
|
Warrant expiration: | Five years
|
Warrant strike price: | $1.80
|
Investor: | Hercules Technology Growth Capital, Inc.
|
Fees: | $150,000
|
Settlement date: | Aug. 5
|
Stock symbol: | Nasdaq: NGSX
|
Stock price: | $2.35 at close Aug. 5
|
Market capitalization: | $38.61 million
|
|
Loan
|
Amount: | $15 million
|
Maturity: | 42 months
|
Coupon: | Floor of 9.5%, based on Prime
|
Call: | With a $600,000 fee
|
|
Accounts receivable line
|
Amount: | $5 million
|
Maturity: | Dec. 31, 2012
|
Coupon: | Floor of 6.75%, based on Prime
|
Call: | Yes
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.